Global Active Pharmaceutical Ingredient Market Research Report 2018-2028

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Active Pharmaceutical Ingredient Picture
1.1.2 Specifications
Table Product Specifications of Active Pharmaceutical Ingredient
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Active Pharmaceutical Ingredient
Table Global Active Pharmaceutical Ingredient Market by Type, 2018-2028 (USD Million)
1.2.1.1 Synthetic API
Table Synthetic API Overview
1.2.1.2 Biotech API
Table Biotech API Overview
1.2.1.3 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Active Pharmaceutical Ingredient
Table Global Active Pharmaceutical Ingredient Market by Application, 2018-2028 (USD Million)
1.2.2.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Table Non-steroidal Anti-inflammatory Drugs (NSAIDs) Overview
1.2.2.2 Oncology Drugs
Table Oncology Drugs Overview
1.2.2.3 Anti-diabetic Drugs
Table Anti-diabetic Drugs Overview
1.2.2.4 Cardiovascular Drugs
Table Cardiovascular Drugs Overview
1.2.2.5 Central Nervous System Drugs (CNS Drugs)
Table Central Nervous System Drugs (CNS Drugs) Overview
1.2.2.6 Musculoskeletal Drugs
Table Musculoskeletal Drugs Overview
1.2.2.7 Other Drugs
Table Other Drugs Overview
1.2.3 by Regions
Table Global Active Pharmaceutical Ingredient Market by Region, 2018-2028 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Active Pharmaceutical Ingredient
2.2 Upstream
Table Cost of Active Pharmaceutical Ingredient
Figure Manufacturing Process of Active Pharmaceutical Ingredient
2.3 Market
2.3.1 SWOT
Figure SWOT of Active Pharmaceutical Ingredient
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Active Pharmaceutical Ingredient
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Active Pharmaceutical Ingredient
3.4 Market Entry
Table Market Entry of Active Pharmaceutical Ingredient
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Synthetic API Market, 2017-2021
Figure Synthetic API Market Size and Growth, 2017-2021 (USD Million)
Figure Synthetic API Market Size and Growth, 2017-2021 (in Volume)
Table Synthetic API CAGR by Revenue and Volume, 2017-2021
4.1.2 Biotech API Market, 2017-2021
Figure Biotech API Market Size and Growth, 2017-2021 (USD Million)
Figure Biotech API Market Size and Growth, 2017-2021 (in Volume)
Table Biotech API CAGR by Revenue and Volume, 2017-2021
4.1.3 Others Market, 2017-2021
Figure Others Market Size and Growth, 2017-2021 (USD Million)
Figure Others Market Size and Growth, 2017-2021 (in Volume)
Table Others CAGR by Revenue and Volume, 2017-2021
4.2 Market Forecast
4.2.1 Synthetic API Market Forecast, 2022-2028
Figure Synthetic API Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Synthetic API Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Synthetic API CAGR by Revenue and Volume, 2018-2028
4.2.2 Biotech API Market Forecast, 2022-2028
Figure Biotech API Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Biotech API Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Biotech API CAGR by Revenue and Volume, 2018-2028
4.2.3 Others Market Forecast, 2022-2028
Figure Others Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Others Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Others CAGR by Revenue and Volume, 2018-2028
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, 2017-2021
Figure Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Non-steroidal Anti-inflammatory Drugs (NSAIDs) CAGR by Revenue and Volume, 2017-2021
5.1.2 Oncology Drugs Market, 2017-2021
Figure Oncology Drugs Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Oncology Drugs CAGR by Revenue and Volume, 2017-2021
5.1.3 Anti-diabetic Drugs Market, 2017-2021
Figure Anti-diabetic Drugs Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Anti-diabetic Drugs CAGR by Revenue and Volume, 2017-2021
5.1.4 Cardiovascular Drugs Market, 2017-2021
Figure Cardiovascular Drugs Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Cardiovascular Drugs CAGR by Revenue and Volume, 2017-2021
5.1.5 Central Nervous System Drugs (CNS Drugs) Market, 2017-2021
Figure Central Nervous System Drugs (CNS Drugs) Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Central Nervous System Drugs (CNS Drugs) CAGR by Revenue and Volume, 2017-2021
5.1.6 Musculoskeletal Drugs Market, 2017-2021
Figure Musculoskeletal Drugs Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Musculoskeletal Drugs CAGR by Revenue and Volume, 2017-2021
5.1.7 Other Drugs Market, 2017-2021
Figure Other Drugs Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Other Drugs CAGR by Revenue and Volume, 2017-2021
5.2 Market Forecast
5.2.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Forecast, 2022-2028
Figure Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Non-steroidal Anti-inflammatory Drugs (NSAIDs) CAGR by Revenue and Volume, 2022-2028
5.2.2 Oncology Drugs Market Forecast, 2022-2028
Figure Oncology Drugs Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Oncology Drugs Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Oncology Drugs CAGR by Revenue and Volume, 2022-2028
5.2.3 Anti-diabetic Drugs Market Forecast, 2022-2028
Figure Anti-diabetic Drugs Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Anti-diabetic Drugs Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Anti-diabetic Drugs CAGR by Revenue and Volume, 2022-2028
5.2.4 Cardiovascular Drugs Market Forecast, 2022-2028
Figure Cardiovascular Drugs Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Cardiovascular Drugs Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Cardiovascular Drugs CAGR by Revenue and Volume, 2022-2028
5.2.5 Central Nervous System Drugs (CNS Drugs) Market Forecast, 2022-2028
Figure Central Nervous System Drugs (CNS Drugs) Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Central Nervous System Drugs (CNS Drugs) Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Central Nervous System Drugs (CNS Drugs) CAGR by Revenue and Volume, 2022-2028
5.2.6 Musculoskeletal Drugs Market Forecast, 2022-2028
Figure Musculoskeletal Drugs Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Musculoskeletal Drugs Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Musculoskeletal Drugs CAGR by Revenue and Volume, 2022-2028
5.2.7 Other Drugs Market Forecast, 2022-2028
Figure Other Drugs Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Other Drugs Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Other Drugs CAGR by Revenue and Volume, 2022-2028
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2017-2021
Figure Asia-Pacific Market Size and Growth, 2017-2021 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2017-2021 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2017-2021
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2017-2021
Figure North America Market Size and Growth, 2017-2021 (USD Million)
Figure North America Market Size and Growth, 2017-2021 (in Volume)
Table North America CAGR by Revenue and Volume, 2017-2021
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2017-2021
Figure Europe Market Size and Growth, 2017-2021 (USD Million)
Figure Europe Market Size and Growth, 2017-2021 (in Volume)
Table Europe CAGR by Revenue and Volume, 2017-2021
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2017-2021
Figure South America Market Size and Growth, 2017-2021 (USD Million)
Figure South America Market Size and Growth, 2017-2021 (in Volume)
Table South America CAGR by Revenue and Volume, 2017-2021
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2017-2021
Figure Middle East & Africa Market Size and Growth, 2017-2021 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2017-2021 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2017-2021
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2022-2028
Figure Asia-Pacific Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2022-2028
6.2.2 North America Market Forecast, 2022-2028
Figure North America Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure North America Market Estimates and Forecasts, 2022-2028 (in Volume)
Table North America CAGR by Revenue and Volume, 2022-2028
6.2.3 Europe Market Forecast, 2022-2028
Figure Europe Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Europe Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Europe CAGR by Revenue and Volume, 2022-2028
6.2.4 South America Market Forecast, 2022-2028
Figure South America Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure South America Market Estimates and Forecasts, 2022-2028 (in Volume)
Table South America CAGR by Revenue and Volume, 2022-2028
6.2.5 Middle East & Africa Market Forecast, 2022-2028
Figure Middle East & Africa Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2022-2028
7 Market Competitive
7.1 Global Market by Vendors
Table Global Active Pharmaceutical Ingredient Market by Vendors, 2017-2021 (in Volume)
Table Global Active Pharmaceutical Ingredient Market Share by Vendors, 2017-2021 (USD Million)
Table Global Active Pharmaceutical Ingredient Market Share by Vendors, 2017-2021 (in Volume)
7.2 Market Concentration
Figure Active Pharmaceutical Ingredient Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Teva
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Novartis
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Johnson & Johnson
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Mylan
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 North China Pharmaceutical Group
Table North China Pharmaceutical Group Profile List
Table Microecological Modulator Operating Data of North China Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Dr. Reddy�s Laboratories
Table Dr. Reddy�s Laboratories Profile List
Table Microecological Modulator Operating Data of Dr. Reddy�s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Roche
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Aurobindo pharma
Table Aurobindo pharma Profile List
Table Microecological Modulator Operating Data of Aurobindo pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Sun Pharmaceutical Industries
Table Sun Pharmaceutical Industries Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Boehringer Ingelheim GmbH
Table Boehringer Ingelheim GmbH Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Bayer
Table Bayer Profile List
Table Microecological Modulator Operating Data of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 BASF
Table BASF Profile List
Table Microecological Modulator Operating Data of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 DSM
Table DSM Profile List
Table Microecological Modulator Operating Data of DSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Zhejiang Medicine
Table Zhejiang Medicine Profile List
Table Microecological Modulator Operating Data of Zhejiang Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Biocon
Table Biocon Profile List
Table Microecological Modulator Operating Data of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 Johnson Matthey
Table Johnson Matthey Profile List
Table Microecological Modulator Operating Data of Johnson Matthey (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.18 Hisun Pharmacy
Table Hisun Pharmacy Profile List
Table Microecological Modulator Operating Data of Hisun Pharmacy (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.19 Cambrex
Table Cambrex Profile List
Table Microecological Modulator Operating Data of Cambrex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.20 Shandong Xinhua Pharmaceutical
Table Shandong Xinhua Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Shandong Xinhua Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.21 Lonza group
Table Lonza group Profile List
Table Microecological Modulator Operating Data of Lonza group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.22 Huahai Pharmaceutical
Table Huahai Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Huahai Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.23 Haerbin Pharmaceutical Group
Table Haerbin Pharmaceutical Group Profile List
Table Microecological Modulator Operating Data of Haerbin Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.24 Cipla
Table Cipla Profile List
Table Microecological Modulator Operating Data of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.25 Tian Yao
Table Tian Yao Profile List
Table Microecological Modulator Operating Data of Tian Yao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.26 Lupin
Table Lupin Profile List
Table Microecological Modulator Operating Data of Lupin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.27 North East Pharmaceutical
Table North East Pharmaceutical Profile List
Table Microecological Modulator Operating Data of North East Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.28 Albemarle
Table Albemarle Profile List
Table Microecological Modulator Operating Data of Albemarle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.29 Shandong Lukang Pharmaceutical
Table Shandong Lukang Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Shandong Lukang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.30 Jiangsu Hengrui Medicine
Table Jiangsu Hengrui Medicine Profile List
Table Microecological Modulator Operating Data of Jiangsu Hengrui Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.31 Bachem
Table Bachem Profile List
Table Microecological Modulator Operating Data of Bachem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.